Skip to main content

Latest SEC Filings — Page 117

Most recent SEC EDGAR filings across all covered tickers, sorted chronologically. Wiseek AI reads each filing and scores it 1–10 for market-moving potential; click through for full analysis.

How Wiseek curates this list

Every filing on this page is sourced directly from SEC EDGAR, the U.S. Securities and Exchange Commission's public filings system. Wiseek processes 8-K, 10-K, 10-Q, Form 4, Form 144, DEF 14A, Schedule 13D/A and related disclosures filed by U.S.-listed companies. The original filing is always linked from each article so readers can verify the source document directly.

How filings get scored

Each filing runs through Wiseek's importance scorer, which weights filing type, deal magnitude, insider participation, material-event flags (going-concern, restatements, executive transitions, M&A) and historical market-reaction patterns. Filings scoring below 7 on the 1–10 scale are filtered out at the database query so this list stays focused on market-moving disclosures. See our methodology for the full rubric.

Editorial standards

Wiseek does not edit the underlying SEC filing. Plain-English summaries and key-event extractions are generated from the verified source text and clearly attributed as AI-generated. Wiseek does not provide investment advice — see our editorial policy for full standards on accuracy, source disclosure, and corrections.

Track by company

Follow all SEC filings for a specific company by visiting its ticker page: AAPL, MSFT, NVDA, TSLA, AMZN, GOOGL, META, JPM, V, UNH, XOM, AVGO, LLY, MA, COST, JNJ, PG, HD, ABBV, MRK, KO, NFLX, AMD, WMT, CVX, BAC — or browse all covered tickers.

James River Group Reports Q1 Net Loss, Underwriting Loss, and New Reinsurance Risk
ProForm 10-QJRVR · Form 10-Q · 3d ago
Douglas Emmett Reports Q1 Net Loss, Lower FFO, and Issues Negative 2026 Guidance
Form 8-KDEI · Form 8-K · 3d ago
Exelixis Reports Strong Q1 2026 Results, Authorizes New $750M Share Buyback, and Zanzalintinib NDA Acceptance
ProForm 10-QEXEL · Form 10-Q · 3d ago
Stockholders Approve Incentive Plan, Authorizing 200,000 Additional Shares
Form 8-KWHG · Form 8-K · 3d ago
Going Concern Warning Issued Amidst SEC Probe and Looming Debt Maturity
ProForm 10-QIIPR · Form 10-Q · 3d ago
Workiva Reports Strong Q1 2026 Results: Swings to Profit, Boosts Cash Flow, and Expands Customer Base
ProForm 10-QWK · Form 10-Q · 3d ago
Flotek Reports Strong Q1 Results, Record Data Analytics Growth, and Positive 2026 Outlook
ProForm 8-KFTK · Form 8-K · 3d ago
Lumentum Reports Strong Q3 Results, Exceeds EPS Estimates, and Issues Robust Q4 Guidance
ProForm 8-KLITE · Form 8-K · 3d ago
Logitech Reports Strong Q4 & Full FY26 Results, Exceeding Prior Year Performance and Providing Positive Q1 FY27 Outlook
ProForm 8-KLOGI · Form 8-K · 3d ago
Astera Labs Reports Record Q1 Revenue and Strong Earnings, Projects Continued Growth in Q2
ProForm 8-KALAB · Form 8-K · 3d ago
MasterBrand Reports Steep Q1 Losses, Weak Q2 Outlook Amid Market Headwinds
ProForm 8-KMBC · Form 8-K · 3d ago
Q1 2026 Results Show Significant Decline to Net Loss Amidst Revenue and EBITDA Drops
ProForm 10-QXPRO · Form 10-Q · 3d ago
Marqeta Achieves GAAP Net Income Profitability in Q1 2026, Reports Strong Growth and Positive Outlook
Form 8-KMQ · Form 8-K · 3d ago
Rapid7 Reports Q1 2026 Results with Revenue Decline, Increased Operating Loss, and Significant Debt Reclassification
ProForm 10-QRPD · Form 10-Q · 3d ago
Navitas Semiconductor Reports Steep Revenue Decline and Doubled Net Loss in Q1 2026
ProForm 10-QNVTS · Form 10-Q · 3d ago
RYTHM Reports Q1 Revenue Surge, Swings to Profit on $70M Fixed Annual Licensing Deal and Tax Benefit; Addresses Going Concern
ProForm 10-QRYM · Form 10-Q · 3d ago
SuRo Capital Reports 76% NAV Increase in Q1, Confirms Strategic Externalization with Magnetar
ProForm 8-KSSSS · Form 8-K · 3d ago
Redwire Reports $304.4M Pro Forma Net Loss for 2025 Following $1.025B Edge Autonomy Acquisition
ProForm 8-KRDW · Form 8-K · 3d ago
Viskase Holdings Adopts Poison Pill to Protect NOLs Amidst Going Concern Doubts
ProForm 8-KENZND · Form 8-K · 3d ago
Entravision Reports Strong Q1 Profit and 114% Revenue Growth, Driven by ATS Segment
ProForm 10-QEVC · Form 10-Q · 3d ago
Carlsmed Reports Strong Q1 Revenue Growth, Improved Margins, and Positive CMS Reimbursement Developments
ProForm 10-QCARL · Form 10-Q · 3d ago
Shareholders Approve New Long-Term Incentive Plan with Significant Potential Dilution
Form 8-KPRGO · Form 8-K · 3d ago
CEO Sells $215K in Shares Amidst Company Stock Repurchase Program
Form 4MYFW · Form 4 · 3d ago
TransDigm Reports Strong Q2 Results, Details Over $4 Billion in Acquisitions, and Continues Share Repurchase Program
ProForm 10-QTDG · Form 10-Q · 3d ago
loanDepot Reports Widened Q1 Net Loss, Halved Adjusted EBITDA Amid Challenging Market
ProForm 8-KLDI · Form 8-K · 3d ago
Banzai International Details Ongoing Dilutive Debt-for-Equity Exchanges and Forbearance Costs
ProForm 8-K/ABNZI · Form 8-K/A · 3d ago
Relay Therapeutics' Zovegalisib Receives FDA Breakthrough Therapy Designation; Reports Strong Q1 Financials and Extended Cash Runway
ProForm 8-KRLAY · Form 8-K · 3d ago
Q1 Results Confirm Merger Progress Amidst Mixed Financials and Acquisition Costs
Form 10-QSLAB · Form 10-Q · 3d ago
Standard BioTools Reports $127.1M Q1 Net Income, Strong Cash Position, and Improved Operations
ProForm 8-KLAB · Form 8-K · 3d ago
Qorvo Exceeds Q4 Revenue Estimates, Repurchases $400M in Shares, Halts Guidance Due to Skyworks Deal
ProForm 8-KQRVO · Form 8-K · 3d ago